Age in itself should not be a factor in deciding whether blood cancer patients are candidates for stem cell transplantation, according to a new study. Blood cancers include leukemia, lymphoma and myeloma. For the study, researchers analyzed long-term outcomes among 372 blood cancer patients aged 60 to 75 who underwent a “mini-transplant,” which is a “kinder, gentler” form of allogeneic (cells from another person) stem cell transplantation developed at the Fred Hutchinson Cancer Research Center in Seattle.
